Suzhou Molarray Co., Ltd. was established in September 2010, with nearly 30,000 square meters of production workshop. It's located in Biobay, a national Biomedical Industrial Park in Suzhou, China. By 2016, a research and development center in Canada and a marketing center in Shanghai were also established. Molarray is now a high-tech enterprise with molecular diagnostic technology as its core. After years of research and development, Molarray has formed an accumulation of independent technology in the areas of "automated control, image processing, optical inspection, microscopy, liquid circuit, electronic applications and software", and has more than 40 patents and about 20 software copyrights. We have independently developed the world's leading "gene detection technology platform", "full-automatic liquid extraction technology platform" and "full-automatic microbial detection technology platform". Based on these technology platforms, Molarray has formed a product portfolio of "fluorescent quantitative PCR detection system, isothermal fluorescent quantitative PCR amplification detector, portable fluorescent quantitative PCR detection system", "nucleic acid extraction and sampling system" and "nucleic acid rapid diagnosis system". Adhering to the enterprise spirit of "Focus, Innovation and User experience", Molarray products are serving the global market wholeheartedly.